J-Lex

Acrasinon injection 20mg

Acrasinon injection 20mg, manufactured by Microbiopharm Japan, contains Aclarubicin hydrochloride, an anthracycline antitumor antibiotic primarily used to treat acute myeloid leukemia and other hematologic malignancies. It has a YJ code of 4235400D1030 and a standard of 20mg 1 bottle.

← Back to search

Need more detailed information?

Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).

More from this manufacturer